{{Rsnum
|rsid=11014166
|Gene=CACNB2
|Chromosome=10
|position=18708798
|Orientation=plus
|GMAF=0.2034
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 38.5 | 50.8 | 10.8
| HCB | 84.1 | 13.6 | 2.3
| JPT | 93.3 | 6.7 | 0.0
| YRI | 75.8 | 24.2 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 84.1 | 13.6 | 2.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}[http://blog.23andme.com/2009/05/12/snpwatch-researchers-find-more-genetic-variations-associated-with-blood-pressure/ 23andMe blog] [[blood pressure]]

{{PMID Auto GWAS
|PMID=19430479
|Trait=Diastolic Blood Pressure
|Title=Genome-wide association study of blood pressure and hypertension
|RiskAllele=A
|Pval=1E-8
|OR=0.37
|ORtxt=[0.25-0.49] mm Hg increase
|OA=1
}}
{{PMID Auto
|PMID=21156931
|Title=Genetic Variation in the {beta}2 Subunit of the Voltage-Gated Calcium Channel and Pharmacogenetic Association With Adverse Cardiovascular Outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES)
|OA=1
}}

{{PMID Auto
|PMID=21963141
|Title=Genetic variations in CYP17A1, CACNB2 and PLEKHA7 are associated with blood pressure and/or hypertension in she ethnic minority of China
}}
{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs11014166
|overall_frequency_n=40
|overall_frequency_d=128
|overall_frequency=0.3125
|n_genomes=26
|n_genomes_annotated=0
|n_haplomes=30
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{PMID Auto
|PMID=23744328
|Title=[Association between CACNB2 gene polymorphisms and essential hypertension]
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}